| Product NDC: | 64125-131 |
| Proprietary Name: | Hydrochlorothiazide |
| Non Proprietary Name: | Hydrochlorothiazide |
| Active Ingredient(s): | 25 mg/1 & nbsp; Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 64125-131 |
| Labeler Name: | Excellium Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA040702 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070601 |
| Package NDC: | 64125-131-10 |
| Package Description: | 1000 TABLET in 1 BOTTLE (64125-131-10) |
| NDC Code | 64125-131-10 |
| Proprietary Name | Hydrochlorothiazide |
| Package Description | 1000 TABLET in 1 BOTTLE (64125-131-10) |
| Product NDC | 64125-131 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070601 |
| Marketing Category Name | ANDA |
| Labeler Name | Excellium Pharmaceutical Inc. |
| Substance Name | HYDROCHLOROTHIAZIDE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |